1. Home
  2. Companies
  3. BB1
  4. Material Events

Blinklab (ASX:BB1) — Material Events

ASX:BB1 · 14 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Significant 14 articles Not Assessed 0 articles
Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed
Significant Score 75–89
14
BlinkLab Nears Key FDA Milestone with Autism and ADHD Trials ExpansionMedium
BlinkLab advances FDA autism and ADHD trials, raises $7.66M, targets regulatory milestones
25 July 2025 ·Quarterly Activities Report ·85
BlinkLab Raises A$17.5M to Advance Autism and ADHD Diagnostic PlatformsMedium
BlinkLab Raises A$17.5M to Advance Autism and ADHD Diagnostic Platforms
16 Apr 2026 ·Capital Raising ·85
BlinkLab Launches Pivotal FDA Trial for Autism Diagnostic AidMedium
BlinkLab Starts FDA 510(k) Validation Study for Autism Diagnostic Aid with First Participant Enrolled
24 Mar 2026 ·Clinical Trial Commencement Announcement ·85
BlinkLab Secures Top US Pediatric Partners to Boost Autism Diagnostic TrialMedium
BlinkLab Adds Two Leading U.S. Pediatric Institutions to FDA Autism Diagnostic Trial Network
26 Aug 2025 ·ASX Announcement ·85
BlinkLab’s Autism Tech Validated in Leading Journal, Paving Way for FDA TrialsMedium
BlinkLab's Autism Diagnostic Technology Validated in Top-Tier Scientific Journal
5 Jan 2026 ·Scientific Validation Announcement ·85
BlinkLab Boosts FDA Autism Trial with Drexel University Joining Elite U.S. NetworkMedium
BlinkLab Expands FDA Autism Diagnostic Trial Network to Nine U.S. Sites Ahead of Q1 2026 Start
12 Feb 2026 ·Clinical Trial Expansion Announcement ·85
BlinkLab Advances FDA Autism Trial and Launches Morocco Screening ProgramHigh
BlinkLab advances FDA autism trial, launches Morocco screening program, raises A$17.7M for growth
30 Apr 2026 ·Quarterly Activities Report and Appendix 4C ·85
BlinkLab Powers Morocco’s Nationwide Autism Screening RevolutionHigh
BlinkLab Selected for Morocco’s Nationwide Government-Funded Autism Screening Program
23 Mar 2026 ·ASX Announcement ·85
BlinkLab Finalises Clinical Network Ahead of Pivotal FDA Autism TrialMedium
BlinkLab Completes Clinical Site Network for Pivotal FDA Autism Diagnostic Trial
16 Mar 2026 ·Clinical Trial Update ·85
BlinkLab’s Dx 1 Pilot Study Surpasses FDA Benchmarks, Poised for Pivotal TrialHigh
BlinkLab's Dx 1 Pilot Study Shows High Accuracy, FDA Trial Ready
22 Oct 2025 ·Clinical Trial Update ·85
BlinkLab Surpasses FDA Benchmarks, Expands Autism Trial Network Ahead of 2026 PushMedium
BlinkLab advances U.S. autism trial with strong pilot results, expands clinical sites, nears European ADHD study completion
30 Jan 2026 ·Quarterly Activities Report ·85
BlinkLab Nears FDA Milestone with Expanded Autism Trial NetworkMedium
BlinkLab advances U.S. autism pilot study with strong results, expands pivotal FDA trial sites, and maintains solid cash position
29 Oct 2025 ·Quarterly Activities Report ·85
BlinkLab Elevates CEO to Managing Director Ahead of Crucial FDA Autism TrialMedium
BlinkLab appoints Dr Henk-Jan Boele as Managing Director ahead of pivotal FDA autism diagnostic trial; board changes announced
18 Dec 2025 ·Board Appointment and Corporate Update ·85
BlinkLab Advances Autism Diagnostics Amid $5.7M Loss and $7.66M Capital RaiseMedium
BlinkLab reports $5.7M loss amid clinical trial progress and $7.66M capital raise
28 Aug 2025 ·Annual Report ·75
Not Assessed Low Score, or missing data
0

No articles in this tier for the last 12 months.